Vitamin D Levels And Myoma Uteri

Vitamin D Levels İn Women With and Without Myoma Uteri

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03871868

Enrollment

300

Registered

2019-03-12

Start date

2018-12-01

Completion date

2019-03-01

Last updated

2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma;Uterus, Polycystic Ovary, Vitamin D Deficiency

Keywords

25-hydroxyvitamin D

Brief summary

Women with at least one uterine leiomyoma and polycystic ovary syndrome over 10 mm and women with normal ultrasonographic findings were included in the study. Blood samples were taken for biochemical analysis such as vitamin D, calcium, magnesium, phosphorus, thyroid stimulating hormone (TSH), hemoglobin (hb), hematocrit (htc), platelet (plt), and albumin. The study groups were compared in terms of these biochemical markers and family history of patients, daily sunshine hours, clothing preferences and education level.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 50 Years

Inclusion criteria

The reproductive age women (25-50 years) with at least one 10 mm or larger diameter leiomyoma detected by transvaginal ultrasound were the study group.

Exclusion criteria

* Patients with a history of myomectomy, * chronic systemic disease * malignancy * history of adenomyosis * women in menopause * pregnant women * vitamin D supplementation * lactation * abortion and pregnancy loss in the last 6 months * oral contraceptive / hormonal agents in the last 3 months

Design outcomes

Primary

Measure	Time frame	Description
Vitamin D levels	december 2018- march 2019	Vitamin D levels in blood test

Countries

Turkey (Türkiye)

Outcome results